Key Highlights

  • Shares were down 8.10 percent to USD 0.3777 in pre-market trading on November 2, 2026.
  • Market reports said a 1-for-5 reverse split is scheduled for Monday, November 9, 2026 (unconfirmed).
  • Cash was USD 1.06 million on June 30, 2026, with Going Concern doubt disclosed.
  • Net comprehensive loss was about USD 3.3 million for the six months ended June 30, 2026.
  • The at-the-market offering capacity was expanded to about USD 4.0 million on October 5, 2026.

What moved Steakholder Foods shares in pre-market trading?

Steakholder Foods (NASDAQ:STKH) was down 8.10 percent to USD 0.3777 in pre-market trading on November 2, 2026. No company announcement dated November 2, 2026 was identified as the trigger.

The decline comes one week before a reverse split that market reports said was recently announced, though no company announcement was identified. Shares that trade below USD 1 and ahead of a share consolidation can see wide swings, and selling pressure from ongoing stock issuance may also play a role.

What is the reverse split and offering activity?

Market reports dated late October 2026 said the stock is scheduled for a 1-for-5 reverse split, effective the morning of Monday, November 9, 2026. A primary company announcement of this split was not identified, so the terms should be treated as unconfirmed. Each American depositary share represented 12,000 ordinary shares in an October 5, 2026 filing, after a one-for-three ADS ratio change effective July 27, 2026.

In a prospectus supplement filed on October 5, 2026, the company raised the aggregate capacity of its at-the-market program to up to USD 4,036,262.

What does Steakholder Foods do and how did it perform?

Steakholder Foods develops 3D bioprinting technology and related ingredients for cultivated meat and plant-based alternatives. It operates as an Israel-based company with American depositary shares listed on Nasdaq.

In a regulatory filing dated August 25, 2026, the company reported no Revenue for the six months ended June 30, 2026. Total comprehensive loss was about USD 3.3 million, compared with about USD 3.8 million a year earlier.

The accumulated Deficit was USD 93.2 million. Net cash used in Operating Activities was USD 3.3 million for the six months.

What are the Balance Sheet risks?

Cash was USD 1.06 million on June 30, 2026, down from USD 3.09 million at December 31, 2025. The filing said the cash balance is insufficient to fund operations for at least 12 months and raises substantial doubt about the ability to continue as a going concern.

Subsequent events included a private Placement that closed on August 3, 2026, with net proceeds of roughly USD 3.1 million, and an Equity line allowing sales of up to USD 8.0 million, of which only about USD 0.4 million had been used. Penny stocks carry risks of volatility, thin Liquidity and dilution.

What should investors watch next?

The first item is how the shares trade through the November 9, 2026 reverse split and whether the adjusted price holds. Further filings on the at-the-market program or equity line would show the pace of dilution.